PDAC
Pipeline by Development Stage
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (3)
Total enrollment: 359 patients across 3 trials
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma
Related Jobs
Senior Medical Science Liaison (Texas/U.S. Oncology)
Senior Medical Science Liaison (Northeast/U.S. Oncology)
Senior Medical Science Liaison (California/U.S. Oncology)
Associate Director Marketing, PDAC
Senior Director Marketing, PDAC
Alternance Assistant(e) Engagement Clients Oncologie H/F
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.